Special Review Decision SRD2021-02, Special Review Decision: Linuron and Its Associated End-use Products
This document presents the final regulatory decision for the special review of linuron. A reference list of information used as the basis for the proposed special review decision is included in PSRD2020-05. Therefore, the complete reference list of all information used in this final special review decision includes the information set out in PSRD2020-05.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada